Meningiom kliniske forsøg i Florida
7 studier for Meningiom søger deltagere på steder i Florida.
Byer i Florida
Officiel studietekst (engelsk)
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Boca Raton Regional Hospital, Boca Raton
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- Holy Cross Hospital, Fort Lauderdale
- og 6 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT02523014Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
- Baptist MD Anderson Cancer Center, Jacksonville
- University of Miami, Miami
- Baptist Health Medical Group Oncology, Miami
- og 1 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06955169A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Mayo Clinic_Jacksonville, Jacksonville
- Baptist Health Miami Cancer Institute, Miami
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT07428616Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- University of Miami, Miami
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT04374305Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- BayCare Health, Clearwater
- Ascension St. Vincent's, Jacksonville
- Miami Cancer Institute, Baptist Health South Florida, Miami
- og 4 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 22. jul. 2026 · NCT04427384Cabozantinib for Patients With Recurrent or Progressive Meningioma
- Miami Cancer Institute at Baptist Health, Inc., Miami
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 14. maj 2026 · NCT05425004Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Mayo Clinic, Jacksonville
- Biogenix Molecular, Miami
RekruttererFase 1/2
Alder 18 til 90 · Alle køn · Opdateret 14. maj 2026 · NCT05636618Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.